Skip to content

Treating Growing Patients With Mandibular Prognathism and Maxillary Constriction

Radiographic Analysis of Skeletal and Dentoalveolar Changes Following the Treatment of Mandibular Prognathism and Maxillary Constriction in Growing Patients Using Two Different Treatment Protocols: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06762418
Enrollment
26
Registered
2025-01-07
Start date
2021-09-15
Completion date
2023-09-15
Last updated
2025-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Class III Malocclusion

Brief summary

This randomized controlled trial intends to test the efficacy of two treatment protocols in the correction of Class III malocclusion with maxillary constriction. We have to options, either to modify the growth using inter-maxillary traction based on an upper fixed appliance that is used in the same time for rapid maxillary expansion or to inhibit mandibular growth by a removable mandibular retractor (RMR) supplied with an expansion screw.

Interventions

DEVICERMR+SME

Patients will be asked to wear this removable appliance for 16 hours daily. The expansion screw is activated twice a week.

DEVICEBAIMT+RME

The elastics are worn 18 hours per day to achieve the sagittal correction. The RME appliance on the upper jaw is activated twice daily until the required expansion is achieved.

Sponsors

Universiti Sains Malaysia
CollaboratorOTHER
Damascus University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
12 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

1. growing male and female patients aged between 12 and 15 years 2. Angle's class III malocclusion 3. skeletal class III relationship judged clinically and confirmed radiographically (-4 \< ANB \< + 1) 4. An anterior crossbite involving two or more teeth or an edge-to-edge incisor relationship with or without an anterior shift of the lower jaw upon closure 5. normal inclination of the lower incisors or slightly proclined (i.e., the IMPA between 85° and 100° 6. maxillary constriction requiring expansion judged clinically and confirmed radiographically 7. permanent dentition 8. no previous orthodontic treatment

Exclusion criteria

1. skeletal class III malocclusion caused predominantly by maxillary deficiency (SNA\<78° with a normal SNB angle) 2. severe skeletal class III presenting mainly due to mandibular protrusion (ANB \< - 4° with no functional shift on closure) 3. contraindications for the use of the mini-screws, such as osteoporosis (addressed with cortisone and its derivatives) or those undergoing radiation treatment 4. a convergence between the mandibular canine root and the first premolar root ,which was assessed radiographically 5. facial asymmetry, characterized by a mandibular midline deviation exceeding 2 mm from the facial midline 6. MM angle \>35° or SN-MP angle \> 40° 7. The existence of cleft lip or craniofacial syndromes and/or palate abnormalities and 8. The existence of supernumerary teeth or missing ones except for the third molars.

Design outcomes

Primary

MeasureTime frameDescription
Change in the GoMe-L1 angleAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsThis angle represents the relationship of the lower anterior teeth with the mandibular plane in the cephalometric analysis in the anteroposterior direction. Lateral cephalograms will be taken, and this angle will be measured in degrees.
Change in the SNA angleAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsThis angle represents the position of the upper jaw in the cephalometric analysis in the anteroposterior direction. Lateral cephalograms will be taken, and this angle will be measured in degrees.
Change in the SNB angleAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthshis angle represents the position of the lower jaw in the cephalometric analysis in the anteroposterior direction. Lateral cephalograms will be taken, and this angle will be measured in degrees.
Change in the ANB angleAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsThis angle represents the relationship between the upper and lower jaws in the cephalometric analysis in the anteroposterior direction. Lateral cephalograms will be taken, and this angle will be measured in degrees.
Change in the SN-GoMe angleAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsThis angle represents the position of the lower jaw in the cephalometric analysis in the vertical direction. Lateral cephalograms will be taken, and this angle will be measured in degrees.
Change in the MM angleAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsThis angle represents the amount of vertical divergence between the upper and lower jaws in the cephalometric analysis. Lateral cephalograms will be taken, and this angle will be measured in degrees.
Change in the SN-SPP angleAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsThis angle represents the position of the upper jaw (represented by the spinal plane SPP) in the vertical direction of the cephalometric analysis. Lateral cephalograms will be taken, and this angle will be measured in degrees.
Change in the Witz appraisalAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsWitz appraisal is measured by the anteroposterior distance between the projections of Points A and B onto the functional occlusal plane, measured in mm. It gives an idea about the sagittal relationship between the upper and lower jaws.
Change in the Co.Go.Me angleAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsThis angle is created by the intersection between the ramus plane (Co.Go) and the mandibular plane (Go.Me). This is called the gonial angle.
Change in the mandibular lengthAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsThis distance is measured between the mandibular condyle (Co) and the genial point (Gn).
Change in the ramus heightAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsThis distance is measured between the mandibular condyle (Co) and mandibular gonial angle (Go).
Change in the lower facial heightAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsThis distance is measured between the anterior nasal spine (ANS) and the lower point on the mandibular symphysis (Me).
Change in the A-H variableAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsThis variable is the horizontal distance between A point (the maxillary bone point) and the perpendicular plane to the S-N plane through Point S (Sella).
Change in the B-H variableAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsThis variable is the horizontal distance between B point (the mandibular bone point) and the perpendicular plane to the S-N plane through Point S (Sella).
Change in the SN-U1At two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsThis angle represents the relationship of the upper anterior teeth with SN in the cephalometric analysis in the anteroposterior direction. Lateral cephalograms will be taken, and this angle is going to be measured in degrees.
Change in the SPP-U1 angleAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsThis angle represents the relationship of the upper anterior teeth with the SPP plane in the cephalometric analysis in the anteroposterior direction. Lateral cephalograms will be taken, and this angle will be measured in degrees.
Change in ls-E Line distanceAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsIt is the distance between Ricketts's esthetic line and the upper lip point.
Change in li-E Line distanceAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsIt is the distance between the lower lip point and esthetic line of Ricketts.
Change in the Gla-Sn-Pog angleAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsIt is the angle between the soft tissue forehead point (Gla) and the subnasal point (Sn) and the most anterior point on the soft tissue chin (Pog).
Change in the naso-labial angleAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsIt is the angle between the upper lip and nasal columella plane.
Change in the labio-mental angleAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsIt is the angle between the lower lip and the chin. It is also called the labio-mental fold angle..
Change in the Ag to MZF-j variableAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsMaxillomandibular width right: measured from the Jugal process to the frontofacial plane. This measurement is measured on the frontal cephalogram.
Change in the J-J distanceAt two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsIt is the maxillary width measured on the frontal cephalogram.
Change in the molar width at the level of apices (M-MRA)At two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsThis is measured between the apices of the palatal roots of the maxillary first molars (R.RA-L.RA) on the frontal cephalogram.
Change in the molar width at the level of cusps (M-MCT)At two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsThis is measured between the mesio-palatal cusps tips of the maxillary first molars (R.CT-L.CT) on the frontal cephalogram.
Change in the inferred molar tipping (M-tip)At two assessment times: (1) one day before the beginning of the treatment, and (2) at the end of the retention phase which is expected to occur within 12 monthsThe difference between R.RA-L.RA and R.CT-L.CT variables mentioned above and the difference is given in mm.

Countries

Syria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026